Consolidated Investment Group’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,000
| Closed | -$787K | – | 66 |
|
|
2025
Q1 | $787K | Sell |
5,000
-11,200
| -69% | -$1.76M | 0.12% | 66 |
|
|
2024
Q4 | $2.54M | Hold |
16,200
| – | – | 0.36% | 49 |
|
|
2024
Q3 | $2.87M | Hold |
16,200
| – | – | 0.43% | 47 |
|
|
2024
Q2 | $2.73M | Sell |
16,200
-13,500
| -45% | -$2.27M | 0.42% | 48 |
|
|
2024
Q1 | $4.94M | Hold |
29,700
| – | – | 0.8% | 33 |
|
|
2023
Q4 | $4.91M | Hold |
29,700
| – | – | 0.87% | 30 |
|
|
2023
Q3 | $4.63M | Hold |
29,700
| – | – | 0.89% | 30 |
|
|
2023
Q2 | $4.63M | Hold |
29,700
| – | – | 0.83% | 31 |
|
|
2023
Q1 | $4.81M | Buy |
29,700
+2,800
| +10% | +$454K | 0.94% | 27 |
|
|
2022
Q4 | $4.3M | Buy |
26,900
+4,700
| +21% | +$751K | 0.92% | 29 |
|
|
2022
Q3 | $3.13M | Buy |
22,200
+1,500
| +7% | +$211K | 0.68% | 43 |
|
|
2022
Q2 | $3.02M | Buy |
20,700
+2,700
| +15% | +$394K | 0.58% | 51 |
|
|
2022
Q1 | $2.92M | Buy |
+18,000
| New | +$2.92M | 0.48% | 55 |
|